(Q36081213)

English

Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

author name string

Levesque MA

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Clark GM

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Yu H

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Diamandis EP

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

0 references

publication date

1 September 1995

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

72

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

720-727

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Protein measurement with the Folin phenol reagent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

p53 is required for radiation-induced apoptosis in mouse thymocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

pS2 is an independent factor of good prognosis in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

Clinical applications of serum and tissue markers in malignant disease: breast cancer as the paradigm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

p53 mutations and overexpression in locally advanced breast cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

Prognostic significance of TP53 alterations in breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

Tumor grade as a prognostic factor in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

Genetic basis for p53 overexpression in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

The p53 tumour suppressor gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

p53 mutations in human cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

Prognostic factors in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

2 October 2017

Quantification of p53 protein in tumor cell lines, breast tissue extracts and serum with time-resolved immunofluorometry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

27 July 2018

The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

27 July 2018

Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

27 July 2018

Cellular accumulation of p53 protein: an independent prognostic factor in stage II breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

27 July 2018

HER-2/neu oncogene protein and prognosis in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

27 July 2018

p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

27 July 2018

Inherited p53 gene mutations in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

27 July 2018

Loss of heterozygosity and p53 gene mutations in breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

23 September 2018

Frequent p53 gene mutations and novel alleles in familial breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

23 September 2018

Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotype. For the International (Ludwig) Breast Cancer Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

23 September 2018

Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

23 September 2018

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

23 September 2018

p53 mutations occur in aggressive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033897

21 October 2018

Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of p53 protein expression in human breast cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aneuploidy fraction but not DNA index is important for the prognosis of patients with stage I and II breast cancer--10-year results

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of p53 gene alterations in node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of p53 and prognosis in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical profile of invasive lobular carcinoma of the breast: predominantly vimentin and p53 protein negative, cathepsin D and oestrogen receptor positive

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association among p53 gene mutation, nuclear accumulation of the p53 protein and aggressive phenotypes in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human breast cancer: frequent p53 allele loss and protein overexpression

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical detection of mutant p53-suppressor gene product in patients with breast cancer: influence on metastasis-free survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 as an independent prognostic marker in lymph node-negative breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 protein expression in breast cancer as related to histopathological characteristics and prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 mutations and histological type of invasive breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High proliferative rates demonstrated by bromodeoxyuridine labeling index in breast carcinomas with p53 overexpression

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 Gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: correlation between immunohistochemical and molecular biology techniques

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic and predictive relevance of c-erbB-2 and ras expression in node positive and negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ectopic production of prostate specific antigen by a breast tumor metastatic to the ovary

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of prostate-specific antigen immunoreactivity in breast tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of p53 overexpression by non-immunohistochemical methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-Specific antigen expression by various tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7545416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1995.400

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36081213&oldid=2198172467"